Skip to main content

Breadcrumb

  1. Home

Clinician: Group/Practice

Valid for Measure Submission

HIV/AIDS: Adolescent and Adult Patients who are Prescribed Potent Antiretroviral Therapy

  • Percentage of patients with a diagnosis of HIV/AIDS, with at least two visits during the measurement year, with at least 90 days between each visit: aged 13 years and older who have a history of a CD4 count less than or equal to 500 cells/mm3; aged 13 years and older who have a history of an AIDS-defining illness, regardless of CD4 count; or who are pregnant, regardless of CD4 count or age, who were prescribed potent antiretroviral therapy

    CBE ID
    0406

HIV/AIDS: CD4 Cell Count or Percentage Performed

  • Percentage of patients aged six months and older with a diagnosis of HIV/AIDS, with at least two CD4 cell counts or percentages performed during the measurement year at least 3 months apart

    CBE ID
    0404

HIV/AIDS: Hepatitis B Vaccination

  • Percentage of patients aged six months and older with a diagnosis of HIV/AIDS, who have received at least one hepatitis B vaccination, or who have documented immunity

    CBE ID
    0412

HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy

  • Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS, who had at least two medical visits during the measurement year, with at least 90 days between each visit, who are receiving potent antiretroviral therapy*, who have a viral load <200 copies/mL after at least 6 months of potent antiretroviral therapy*

    *Potent antiretroviral therapy is described as any antiretroviral therapy that has demonstrated optimal efficacy and results in durable suppression of HIV as shown by prior clinical trials

    CBE ID
    0407

HIV/AIDS: Medical Visit

  • Percentage of patients, regardless of age, with a diagnosis of HIV/AIDS, with at least two medical visits during the measurement year, with a minimum of 90 and 180 days between each visit

    CBE ID
    0403

HIV/AIDS: Other Infectious Diseases - Hepatitis C

  • Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS for whom Hepatitis screening was performed at least once since the diagnosis of HIV infection, or for whom there is documented immunity

    CBE ID
    0414